COLLEGIUM PHARMACEUTICAL INC
NASDAQ: COLL (Collegium Pharmaceutical, Inc.)
最近更新时间: 8小时之前27.01
-0.01 (-0.04%)
| 前收盘价格 | 27.02 |
| 收盘价格 | 27.00 |
| 成交量 | 217,949 |
| 平均成交量 (3个月) | 406,456 |
| 市值 | 867,879,936 |
| 市盈率 (P/E TTM) | 14.52 |
| 预期市盈率 (P/E Forward) | 3.95 |
| 价格/销量 (P/S) | 1.73 |
| 股市价格/股市净资产 (P/B) | 3.79 |
| 52周波幅 | |
| 利润日期 | 7 May 2025 - 12 May 2025 |
| 营业毛利率 | 10.96% |
| 营业利益率 (TTM) | 23.97% |
| 稀释每股收益 (EPS TTM) | 1.86 |
| 季度收入增长率 (YOY) | 21.50% |
| 季度盈利增长率 (YOY) | -60.80% |
| 总债务/股东权益 (D/E MRQ) | 428.20% |
| 流动比率 (MRQ) | 0.950 |
| 营业现金流 (OCF TTM) | 204.98 M |
| 杠杆自由现金流 (LFCF TTM) | 362.08 M |
| 资产报酬率 (ROA TTM) | 8.89% |
| 股东权益报酬率 (ROE TTM) | 32.62% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Collegium Pharmaceutical, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.88 |
|
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 1.44% |
| 机构持股比例 | 118.15% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Eventide Asset Management, Llc | 31 Dec 2024 | 2,638,702 |
| Pacer Advisors, Inc. | 31 Dec 2024 | 2,142,491 |
| Principal Financial Group Inc | 31 Dec 2024 | 1,645,051 |
| Emerald Advisers, Llc | 31 Dec 2024 | 811,680 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 50.00 (HC Wainwright & Co., 85.12%) | 购买 |
| 中 | 46.00 (70.31%) | |
| 低 | 36.00 (Piper Sandler, 33.28%) | 保留 |
| 平均值 | 44.00 (62.90%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 29.29 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Needham | 09 Apr 2025 | 46.00 (70.31%) | 购买 | 26.37 |
| HC Wainwright & Co. | 24 Mar 2025 | 50.00 (85.12%) | 购买 | 30.56 |
| Piper Sandler | 04 Feb 2025 | 36.00 (33.28%) | 保留 | 30.93 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合